MESO logo
NASDAQ · MESOBiotechnologyUpdated Nov 2, 2026

Mesoblast Limited enterprise value

Company valuation, historical trends, and peer comparisons.

The Enterprise Value as of November 2026 (TTM) for Mesoblast Limited (MESO) is 2.05B

According to Mesoblast Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 2.05B. This represents a change of 0.18% compared to the average of 2.04B of the last 4 quarters.

Mesoblast Limited (MESO) Historical Enterprise Value (quarterly & annually)

How has MESO Enterprise Value performed in the past?

The mean historical Enterprise Value of Mesoblast Limited over the last ten years is 845.48M. The current 2.05B Enterprise Value has changed 142.21% with respect to the historical average. Over the past ten years (40 quarters), MESO's Enterprise Value was at its highest in in the December 2025 quarter at 2.35B. The Enterprise Value was at its lowest in in the December 2023 quarter at 221.98M.

Quarterly (TTM)
Annual

Average

845.48M

Median

736.58M

Minimum

305.83M

Maximum

1.84B

Mesoblast Limited (MESO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mesoblast Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.54%

Maximum Annual Enterprise Value = 1.84B

Minimum Annual Increase = -62.77%

Minimum Annual Enterprise Value = 305.83M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20261.84B51.29%
20251.21B70.08%
2024713.46M23.70%
2023576.75M88.59%
2022305.83M-62.77%
2021821.52M-26.20%
20201.11B107.54%
2019536.33M-7.34%
2018578.82M-23.81%
2017759.69M98.49%

Mesoblast Limited (MESO) Average Enterprise Value

How has MESO Enterprise Value performed in the past?

The current Enterprise Value of Mesoblast Limited (MESO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.25B

5-year avg

929.06M

10-year avg

845.48M

Mesoblast Limited (MESO) Enterprise Value vs. Peers

How is MESO’s Enterprise Value compared to its peers?

Mesoblast Limited’s Enterprise Value is less than Legend Biotech Corporation (3.56B), greater than Celularity Inc. (62.23M), greater than Lineage Cell Therapeutics, Inc. (214.08M), greater than Capricor Therapeutics, Inc. (479.55M), greater than Fate Therapeutics, Inc. (276.36M),

Build a custom stock screener for Mesoblast Limited (MESO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mesoblast Limited (MESO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Mesoblast Limited's Enterprise Value?

What is the highest Enterprise Value for Mesoblast Limited (MESO)?

What is the 3-year average Enterprise Value for Mesoblast Limited (MESO)?

What is the 5-year average Enterprise Value for Mesoblast Limited (MESO)?

How does the current Enterprise Value for Mesoblast Limited (MESO) compare to its historical average?